GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(39494)

  • GC81556 structure
    GC81556FZ1 peptide
    Purity: >99.50%

    FZ1 peptide is a cyclic heptapeptide and also an integrin αvβ3 agonist.

  • GC81557 structure
    GC81557Zilebesiran sodium
    CAS: 2380166-34-5
    Purity: >94.50%

    Zilebesiran (AD-85481; ALN-AGT) sodium is a long-acting liver-targeted small interfering RNA (siRNA) antihypertensive agent.

  • GC81558 structure
    GC81558ANT308 TFA
    Purity: >99.50%

    ANT308 TFA is a vasoactive intestinal polypeptide ( VIP receptor ) antagonist.

  • GC81559 structure
    GC81559Maxadilan TFA
    Purity: >96.00%

    Maxadilan TFA is a specific irreversible PAC1 receptor agonist and a potent vasodilator peptide present in the salivary glands of sand flies.

  • GC81560 structure
    GC81560GRK2 degrader-1
    CAS: 3052947-04-0
    Purity: >98.50%

    GRK2 degrader-1 (compound 1) is a potent and orally active GRK2 degrader.

  • GC81561 structure
    GC81561GR-11-1
    Purity: >98.50%

    GR-11-1 is a GRK2 substrate for phosphorylation.

  • GC81562 structure
    GC81562GUB08248 acetate
    Purity: >98.50%

    GUB08248 acetate is a full GPR10 agonist and a partial NPFF2R agonist, with EC 50 values of 0.5 nM and 2.5 nM, respectively.

  • GC81563 structure
    GC81563GUB10194 acetate
    Purity: >98.50%

    GUB10194 acetate is a fully potent and selective GPR10 agonist with an EC 50 of 15 nM.

  • GC81564 structure
    GC81564Z52
    CAS: 3077480-59-9
    Purity: >98.50%

    Z52 is a Ras protein inhibitor.

  • GC81565 structure
    GC81565palm11-PrRP31 TFA
    Purity: >99.00%

    palm11-PrRP31 TFA is a lipidized endogenous appetite inhibitory neuropeptide (PrRP) analogue.

  • GC81566 structure
    GC81566Ro 25-1553 TFA
    Purity: >99.00%

    Ro 25-1553 TFA is a 31 amino acid vasoactive intestinal peptide (VIP) analog, that acts as an agonist for VIP2 receptor ( VPAC2 receptor ).

  • GC81567 structure
    GC81567Ro 25-1553 acetate
    Purity: >98.00%

    Ro 25-1553 acetate is a selective VIP 2 receptor ( VPAC 2 receptor ) agonist.

  • GC81568 structure
    GC81568M464
    Purity: >99.50%

    M464, a non-steroidal anti-inflammatory compound, is a potent and orally active NLRP3 inflammasome inhibitor.

  • GC81569 structure
    GC81569Elfetabart
    CAS: 3061153-83-8
    Purity: >99.00%

    Elfetabart (DB-1311 Antibody; BNT324 Antibody) is a humanized monoclonal antibody targeting CD276 with antitumor activity.

  • GC81570 structure
    GC81570Daxdilimab (FUT8-KO)
    Purity: >97.00%

    Daxdilimab (FUT8-KO) is an anti- ILT7 monoclonal antibody expressed by CHO cells with the fucosyltransferase 8 gene (FUT8) knocked out.

  • GC81571 structure
    GC815713,4,6-Tri-O-galloyl-D-glucose
    CAS: 99523-99-6
    Purity: >98%

    3,4,6-Tri-O-galloyl-D-glucose (3,4,6-Trigalloylglucose) is an α-amylase ( porcine α-amylase IC 50 = 334.6 μM; K i = 307.5 μM) and α-glucosidase ( yeast α-glucosidase IC 50 = 46.5 μM; K i = 39.9 μM) mixed type inhibitor.

  • GC81572 structure
    GC81572Glutathione trisulfide TFA
    Purity: >99.00%

    Glutathione trisulfide TFA (GSSSG TFA) is an orally active, blood-brain barrier permeable neuroprotective agent.

  • GC81573 structure
    GC81573Indigoidine
    CAS: 2435-59-8
    Purity: >98%

    Indigoidine is a natural biological pigment that appears in a bright blue color and is a natural blue dye with industrial applications.

  • GC81574 structure
    GC81574Hydroxyproline
    CAS: 6912-67-0
    Purity: >98.00%

    Hydroxyproline (DL-Hydroxyproline) is a non-essential amino acid and one of the main components of collagenous tissues.

  • GC81575 structure
    GC81575ZIP14-IN-1
    CAS: 1048-17-5
    Purity: >99.50%

    ZIP 14-IN-1 (PPTD) is a selective and orally active ZIP14 inhibitor.

  • GC81576 structure
    GC81576USF 2550A
    CAS: 5192-62-1
    Purity: >98%

    USF 2550A is a class of fungus-derived 2-pyran compound with DPPH free radical scavenging activity.

  • GC81577 structure
    GC81577Mono N-desmethyl disperse polyester dark blue
    CAS: 56524-77-7
    Purity: >98%

    Mono N-Desmethyl Disperse Polyester Dark Blue is a bioreductive agent that is activated under hypoxic conditions.

  • GC81578 structure
    GC81578Disperse polyester dark blue
    CAS: 56524-76-6
    Purity: >98%

    Disperse Polyester Dark Blue is a chemical compound extensively employed in scientific research.

  • GC81579 structure
    GC81579Ophthalmic acid TFA
    Purity: >98.00%

    Ophthalmic acid TFA is a ubiquitous metabolite and glutathione modulator, with a K i of 0.95 mM for glyoxalase I.